Switch View
© PR Newswire
10.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit - LNTH
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NUTX
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Levi & Korsinsky Notifies Semler Scientific, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SMLR
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
10.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Investors who lost money on Cytokinetics, Incorporated(CYTK) should contact Levi & Korsinsky about pending Class Action - CYTK
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
10.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
October 25, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against LFMD
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US42328V8761
Solana Company
HSDT
LISTED
NASDAQ
Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings
News Preview
Solana Company (NASDAQ:HSDT) (“HSDT” or “the Company”), formerly known as Helius Medical Technologies, Inc., today announced it has selected BitGo, the digital asset infrastructure company, to serve as a custodian for the Company’s holdings of SOL, the native asset of the Solana Network. The partnership supports Solana Company’s digital asset trea...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: CA5527671054
Me Therapeutics H
LISTED
XETRA
ME Therapeutics Added to CSE25 Index
News Preview
ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) (CSE: METX) (FSE: Q9T), a publicly listed biotechnology company discovering and developing novel cancer fighting drugs in the field of immuno-oncology, announced today it has been added to the CSE25 Index, a signature benchmark of the Canadian Securities Exchange.
The CSE25 Index...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US9286611077
VolitionRX Ltd
VNRX
LISTED
XASE
VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants
News Preview
HENDERSON, Nev., Oct. 10, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an underwritten public offering of 11,550,000 shares of its common stock and warrants to purchase up to 11,550,000 shares of i...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
INVESTOR ALERT: Berger Montague Advises LifeMD, Inc. (NASDAQ: LFMD) Investors to Inquire About a Securities Fraud Class Action by October 27, 2025
News Preview
PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Clas...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US8256932034
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
LISTED
NASDAQ
Shuttle Executes LOI with Molecule.ai
News Preview
GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with Molecule.ai....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
10.10.2025
ISIN: US1508377066
CEL-SCI Corp
CVM
LISTED
XASE
CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference
News Preview
Vienna, Virginia--(Newsfile Corp. - October 10, 2025) - CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced that Geert Kersten, Chief Executive Officer, is scheduled to present at the LD Micro "Main Event" Investor Conference on October 21, 2025 at 9:30 a.m. PST. The Conference is taking place a...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
News Preview
17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression
New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 data evaluates the impact on sexual...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US74907L3006
Quoin Pharmaceuticals Ltd.
QNRX
LISTED
NASDAQ
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
News Preview
PIPE financing included participation from leading healthcare-focused institutional investors including AIGH Capital Management, Soleus Capital, Nantahala Capital, Diadema Partners, Stonepine Capital Management, ADAR1 Capital Management, and Velan Capital, among others PIPE financing included participation from leading healthcare-focused institutio...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US98888T1079
ZimVie, Inc.
ZIMV
LISTED
NASDAQ
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
News Preview
PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the “Merger”) pursuant to the terms and conditions of the Agr...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking clinical study results from the nPulse™ Cardiac Surgical System first-in-human feasibility study at the 39th European Association for Card...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet to Host Investor Day on November 20, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton, Massachusetts headquarters on Thursday, November 20, 2025.
The Investor Day will include presentations from the management team highlighting the...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
News Preview
Bristol Myers Squibb (NYSE: BMY, “BMS”) and Orbital Therapeutics (“Orbital”) today announced a definitive agreement under which BMS will acquire Orbital, a privately held biotechnology company pioneering a new generation of RNA medicines that reprogram the immune system in vivo, enabling treatments that provide the precision, control, and flexibil...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced the launch of its COBENFY Connections™ initiative in partnership with culinary expert, TV host and author Gail Simmons.* Launching on World Mental Health Day, the initiative features real stories from people affected by schizophrenia, including Simmons, who shares her perspective through her brother...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: CH0334081137
CRISPR Therapeutics AG
CRSP
LISTED
NASDAQ
CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform
News Preview
-Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile-...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US01625V1044
Alignment Healthcare Inc
ALHC
LISTED
NASDAQ
Alignment Healthcare Maintains High 2026 Star Ratings from Medicare, 100% of Members Enrolled in Plans Rated 4 Stars or Higher for Second Consecutive Year
News Preview
Medicare Advantage company adds second 5-star HMO contract in Nevada, Texas HMO earns 4.5 stars in first year Medicare Advantage company adds second 5-star HMO contract in Nevada, Texas HMO earns 4.5 stars in first year...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
News Preview
Industry leader brings 40 years of executive and board experience across the global medical technology sector...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US15687V1098
Certara Inc
CERT
LISTED
NASDAQ
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
News Preview
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
News Preview
CHICAGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $500,000 worth of Ethereum (ETH), bringing its total investment in ETH to $1.5 million....
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces New Franchise Agreement Signed for Heal Wellness in Barrie, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce the signing of a franchise agreement for the city of Barrie, Ontario. This is the second franchise agreement Hea...
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma
News Preview
75% of OST-HER2 treated patients achieved 2-year overall survival compared with 40% in the historical control group (p < 0.0001)100% of patients who achieved 12 month event free survival achieved 2 year overall survivalNew York, New York--(Newsfile Corp. - October 10, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Compa...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US0327973006
Anavex Life Sciences Corp
AVXL
LISTED
NASDAQ
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
News Preview
Presentation title: “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine” Presentation title: “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine”...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
News Preview
Scientific presentations reveal how Seer’s Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protein isoform-specific biomarkers Scientific presentations reveal how Seer’s Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protei...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
News Preview
Brand Institute Partnership...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
News Preview
MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today published Inspire V clinical outcomes data from its Singapore clinical...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Monthly Fact Sheet as at 30 September 2025
News Preview
Worldwide Healthcare Trust PLC...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2025
ISIN: US42227W1080
Healthcare Triangle, Inc.
HCTI
LISTED
NASDAQ
Healthcare Triangle Executes Aggressive Growth Strategy, Announcing Within One Week Both $34 Million Planned Acquisition Revenue and Processing of $20 Million in Revenue Generated by Healthcare Providers on Ezovion Platform
News Preview
Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc. (Nasdaq:HCTI), a leader in digital transformation solutions for the healthcare and life sciences industries, has announced two significant developments within th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies (OTC PINK:MDCE) Highlights How AI Is Accelerating Life-Changing Medical Research - Responsibly
News Preview
MESA, ARIZONA / ACCESS Newswire / October 10, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging leader in artificial intelligence-powered preventive health technologies, today highlighted the essential role of medical expertise, certified imaging data, and regulatory standards in developing trustworthy AI healthcare solutions. The...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2025
ISIN: US42227W1080
Healthcare Triangle, Inc.
HCTI
LISTED
NASDAQ
Healthcare Triangle, a $16M Microcap, Targets Teyame.AI and Its $34M FY2025 (NASDAQ: HCTI)
News Preview
PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Some companies tiptoe into innovation. Healthcare Triangle Inc. (NASDAQ:HCTI) prefers to kick the door down. The Pleasanton-based digital health firm, valued at just $16.1 million and lifted by a 27% rise in its share price to $2.76 since the start of September, is working to complete a strategi...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Stockholder Alert: Robbins LLP Informs aTyr Pharma, Inc. Stockholders that a Class Action Lawsuit was Filed Against the Company
News Preview
SAN DIEGO, Oct. 10, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired aTyr Pharma, Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025. aTyr is a clinical stage biotechnology company lever...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia successfully completes an upsized offering of shares – funding the company to overall profitability
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 9, 2025 /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate failed to meet its primary endpoint in a critical Phase 3 trial....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: KYG970081173
WuXi Biologics (Cayman) Inc
2269
LISTED
HKSE
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year
News Preview
SHANGHAI, Oct. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has received the esteemed AAA ESG rating from Morgan Stanley Capital International (MSCI) for the third consecutive year.
This top-...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2025
ISIN: GB00BP2C3V08
Genflow Biosciences Plc
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Update on Animal Health Program
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
If you suffered losses in Savara between March 7, 2024 and May 23, 2025 and would like...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: KR7068270008
Celltrion Inc
68270
LISTED
KSC
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
News Preview
EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and diabetic retinopathy (DR)
Celltrion plans to enter the U.S. ophthalmology market to meet di...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
If you suffered losses in Semler Scientific between March 10, 2021 and April...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses in Cytokinetics between December 27, 2023 and May 6, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
If you suffered losses in LifeMD between May 7, 2025 and August 5, 2025 and would like...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Biopharma-Führungskräfte bringen die Zukunft der Biowissenschaften auf dem Veeva Commercial Summit Europe voran
News Preview
Branche trifft sich, um die KI-Innovationen von Veeva zu erkunden und Ideen mit Unternehmen wie Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna und MSD auszutauschen
BARCELONA, Spanien, 10. Oktober 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ga...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: CA74764Y2050
Quantum Biopharma Ltd
QNTM
LISTED
NASDAQ
KILL Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM
News Preview
DJS Law Group requests that their press release NewsItemId: 20251009668999 issued October 9, 2025 “Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM” be killed.
The release was issued in error by DJS Law Group
A replacement release will not be issued....
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: CA74764Y2050
Quantum Biopharma Ltd
QNTM
LISTED
NASDAQ
Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of Quantum BioPharma Ltd. (“Quantum BioPharma” or “the Company”) (NASDAQ: QNTM) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertin...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: CA74764Y2050
Quantum Biopharma Ltd
QNTM
LISTED
NASDAQ
KILL QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm requests that their press release NewsItemId: 20251009948258 issued Oct. 9, 2025 “QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm” be killed.
The release was issued in error by The Schall Law Firm.
A replacement release will not be issued....
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: CA74764Y2050
Quantum Biopharma Ltd
QNTM
LISTED
NASDAQ
QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quantum BioPharma Ltd. (“Quantum BioPharma” or “the Company”) (NASDAQ: QNTM) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026
News Preview
HARTFORD, Conn., Oct. 9, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Med...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK
News Preview
NEW YORK, Oct. 9, 2025 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinet...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces New Employment Inducement Grants
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 60,300 shares of the Co...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB) today announced the presentation of longer-term follow-up analyses from the ongoing open-label extension (OLE) studies of zorevunersen that support the poten...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals.
This agreement grants Phibro exclusive rights to develop, manufacture, an...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Declares Fourth-Quarter 2025 Dividend
News Preview
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 fourth-quarter 2025 dividend on the company’s common stock, payable December 1, 2025, to holders of the Common Stock of record at the close of business on November 7, 2025. The fourth-quarter 2025 cash dividend will be the 348th consecutive quarterly dividend paid...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
News Preview
Johnson & Johnson (NYSE: JNJ) will present at the UBS Global Healthcare Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archi...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 6, 2025 to discuss the Company's financial results for its fourth quarter...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2025
ISIN: US98978V1035
Zoetis Inc
ZTS
LISTED
NYSE
Zoetis Declares Fourth Quarter 2025 Dividend
News Preview
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on Tuesday, December 2, 2025, to all holders of record of the Company’s common stock as of the close of business on Friday, October 31, 2025.
About Zoetis
As the world’s leading animal health com...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
